Ultrasound-guided percutaneous peripheral nerve stimulation for chronic refractory neuropathic pain: a unique series

During the last two decades, with the advent of recent technology, peripheral nerve stimulation has become an appealing modality at the forefront of pain management. In this case series, we document the clinical rationale and technical considerations on three of the most challenging cases, refractor...

Full description

Saved in:
Bibliographic Details
Published inPain management Vol. 13; no. 1; pp. 15 - 24
Main Authors Ferreira-Silva, Nuno, Ferreira-Dos-Santos, Guilherme, Gupta, Sahil, Hunt, Christine L, Eldrige, Jason S, Pingree, Matthew J, Clendenen, Steven R, Hurdle, Mark Friedrich B
Format Journal Article
LanguageEnglish
Published England Future Medicine Ltd 01.01.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:During the last two decades, with the advent of recent technology, peripheral nerve stimulation has become an appealing modality at the forefront of pain management. In this case series, we document the clinical rationale and technical considerations on three of the most challenging cases, refractory to previous interventions, that were treated by our team with an ultrasound-guided percutaneous peripheral nerve stimulator targeting the musculocutaneous, bilateral greater occipital and subcostal nerves. At the 6-month follow-up, all patients experienced greater than 50% relief of baseline pain, with a near-complete resolution of pain exacerbations. Furthermore, to our knowledge, this is the first report of an ultrasound-guided percutaneous technique of a peripheral nerve stimulator targeting the musculocutaneous and subcostal nerves. Peripheral nerve stimulation is a new tool used in the treatment of peripheral nerve pain. In this study, we share our experience using this technology in three unusual, difficult-to-treat chronic nerve pain presentations, targeting the musculocutaneous, bilateral greater occipital and subcostal nerves. All patients were asked about how pain levels had changed since the peripheral nerve stimulation device had been implanted. In every case, patients reported a decline in their pain level from day one. After 6 months of peripheral nerve stimulator use, all patients reported a greater than 50% pain relief.
ISSN:1758-1869
1758-1877
DOI:10.2217/pmt-2022-0070